Recombinant DNA Advisory Committee - 12/3-4/92 
Janet Peterson, University of Maryland, Baltimore 
Anne Petruska, The Blue Sheet 
Bruce Pratt, Genzyme Corporation 
Raj Puri, Food and Drug Adminstration 
Judy Randal, Freelance Writer 
Abdur Razzarque, Food and Drug Adminstration 
Paul Recer, Associate Press, Inc. 
Peter Reinecke, United States Senate staff 
Devra Rich, University of Iowa 
Steve Richieri, Immune Response, Inc. 
Joseph Rokovich, Somatix TTierapy 
Ivor Royston, San Diego Cancer Center 
John Russick, National Museum of American History 
Laurence Schaffar, Association Francaise de Lutte Contre La Mucoviscidose 
Steven Shak, Genentech, Inc. 
Tomiko Shimada, Ambiance Awareness International 
Nina Siegler, Rock Creek Research 
Richard Simon, University of Michigan 
Jonathan Simons, Johns Hopkins University 
Alan Smith, Genzyme Corporation 
Herb Simith, Food and Drug Adminstration 
Patti Sowa, Dupont-Merck Pharmaceuticals 
Mark Stewart, University of Virginia 
Henri Termeer, Genzyme Corporation 
Larry Thompson, Science Magazine 
Paul Tolstoshev, Genetic Therapy, Inc. 
Bruce Trapnell, Genetic Therapy, Inc. 
Dominick Vacante, Microbiological Association 
Petri Vainio, Siera Ventures 
Thierry Velu, Brussels University 
Mel Wabuke, Baxter Health Care 
Michael Welsh, University of Iowa 
Jim Wilson, University of Michigan 
Savio Woo, Baylor College of Medicine 
Yiping Yang, University of Michigan 
Joseph Zabner, University of Iowa 
Gregory Zale, Prince Ventures 
Beth Ziemann, Bristol-Myers Squibb Company 
[536] 
Recombinant DNA Research, Volume 16 
